Posted 18 June, 2021
iSpecimen Inc. IPO completed
IPO completed detected for ticker Nasdaq:ISPC in a 424B4 filed on 18 June, 2021.
This is a firm commitment initial public offering of common stock of iSpecimen Inc.
Don't know how to trade IPO completion? Read Initial Public Offerings.
Overview of iSpecimen Inc.
None • None
iSpecimen, Inc. is a healthcare organization that engages in procurement of human biospecimen. It collects biofluids, human tissue, hematopoietic stem, and immune cells. The company was founded by Christopher Ianelli in July 2009 and is headquartered in Lexington, MA.Market Cap
$4.25M
View Company Details
$4.25M
Interested in special situations?
Join Tickerverse
- customize event filters
- create watchlists, bookmarks
- get email notifications for the latest special situations
- browse and analyze public companies, executives and SEC filings
Tickerverse is a great way to find investment opportunities in corporate actions.
By signing up you agree to our Terms of Service and Privacy Policy.